Rectal cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up

Rob Glynne‐Jones(Mount Vernon Cancer Centre), Lucjan Wyrwicz(The Maria Sklodowska-Curie National Research Institute of Oncology), Emmanuel Tiret(Sorbonne Université), Gina Brown(Royal Marsden NHS Foundation Trust), Claus Rödel(Goethe University Frankfurt), Andrés Cervantes(INCLIVA Health Research Institute), Dirk Arnold
Annals of Oncology
May 5, 2017
10.1093/annonc/mdx224
Cited by 2,031Open Access
Full Text

Abstract

Related Papers

TNM Classification of Malignant Tumours
|Unknown|1987|16.1k
The consensus molecular subtypes of colorectal cancer
Justin Guinney, Rodrigo Dienstmann, Xin Wang et al.|Nature Medicine|2015|5.2k
Pathologic assessment of tumor regression after preoperative chemoradiotherapy of esophageal carcinoma. Clinicopathologic correlations
A.M. Mandard, Frédéric Dalibard, J.-C. Mandard et al.|Cancer|1994|2k
Prognostic factors in colorectal carcinomas arising in adenomas: Implications for lesions removed by endoscopic polypectomy
Rodger C. Haggitt, Raymond E. Glotzbach, Edward E. Soffer et al.|Gastroenterology|1985|748
Oxaliplatin added to fluorouracil-based preoperative chemoradiotherapy and postoperative chemotherapy of locally advanced rectal cancer (the German CAO/ARO/AIO-04 study): final results of the multicentre, open-label, randomised, phase 3 trial
Claus Rödel, Ullrich Graeven, Rainer Fietkau et al.|The Lancet Oncology|2015|723